Peng Chen

ORCID: 0009-0006-5418-3916
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neonatal and fetal brain pathology
  • Protein Degradation and Inhibitors
  • Neuroblastoma Research and Treatments
  • Hemoglobinopathies and Related Disorders
  • Renal and related cancers
  • Cancer therapeutics and mechanisms
  • Traditional Chinese Medicine Studies

First Affiliated Hospital of GuangXi Medical University
2016-2024

Guangxi Medical University
2016-2024

This study aimed to analyze the expression and prognosis of SRY-box transcription factor 11 (SOX11) in neuroblastoma (NB), as well biological function potential regulatory mechanism SOX11 NB.

10.4174/astr.2024.106.5.284 article EN Annals of Surgical Treatment and Research 2024-01-01

Cuproptosis, a recently identified type of programmed cell death triggered by copper, has mechanisms in Wilms tumor (WT) that are not yet fully understood. This research focuses on examining the link between WT and Cuproptosis-related genes (CRGs), with goal developing predictive model for WT. Four gene expression datasets related to were sourced from GEO database. Subsequently, profiles CRGs extracted differential analysis immune infiltration studies. Utilizing 105 samples, clusters...

10.1186/s12911-024-02716-8 article EN cc-by-nc-nd BMC Medical Informatics and Decision Making 2024-11-04

Objective:To preliminarily explore the clinical significance of extended high frequency audiometry in evaluating early hearing loss for thalassemia.Method:Pure tone audiometry(PTA) included conventional pure and were obtained on pre post-treatment day 60(117 ears) patients from September 2013 to October 2014. Result:The averages 117 cases were(15.72±11.62)dBHL pre-treatment and(15.40±12.24)dBHL day. There no significant differences PTA(P >0.05). But without detection rate was higher than...

10.13201/j.issn.1001-1781.2016.10.009 article EN PubMed 2016-05-20
Coming Soon ...